Poniard completes equity-based line of credit

Poniard Pharmaceuticals Inc. (NASDAQ:PARD), South San Francisco, Calif. Business: Cancer Date completed: 12/22/09 Type: Equity-based line of credit Raised: $6.5 million Shares: 3.5 million Price: $1.8...